Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-ST2 in COPD
NCT03615040Phase 2Completed
- Sponsor
- University of Leicester
- Start
- Oct 2018
- Primary completion
- May 2020
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of astegolimab in chronic obstructive pulmonary disease (COPD), sponsored by University of Leicester. Started Oct 2018; status: completed.
02
Drugs
astegolimab
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03615040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03615040.